All News #Library
Biotech
GC Bio Boosts IVIG Safety With Advanced Prothrombotic Impurity
06 Apr 2026 //
PR NEWSWIRE
GC Bio Pharma Secures Marketing Approval For Varicella Vaccine
26 Mar 2026 //
PR NEWSWIRE
GC Biopharma Releases Review Paper On 30-Year Data For Varicella
11 Mar 2026 //
PR NEWSWIRE
GC Biopharma Ships First Doses Of Recombinant Anthrax Vaccine
08 Dec 2025 //
PR NEWSWIRE
GC Bio Varicella Vaccine `MAV/06` Listed In WHO Position Paper
02 Dec 2025 //
PR NEWSWIRE
GC Bio Enhances IG Therapy Care Insights at IgNS Annual Meeting
06 Nov 2025 //
PR NEWSWIRE
Gcbio`s BARYTHRAX, Shows Safety, Immunogenicity In Phase 2
03 Nov 2025 //
PR NEWSWIRE
GC Bio To Host Symposium On Primary Immunodeficiency At Meeting
15 Oct 2025 //
PR NEWSWIRE
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo
13 Oct 2025 //
PR NEWSWIRE
GC Biopharma Showcases IVIG Innovation at Fall CIIC Conference
13 Oct 2025 //
PR NEWSWIRE
GC Biopharma Submits IND For Ph 1 COVID-19 mRNA Vaccine In Korea
22 Sep 2025 //
PR NEWSWIRE
GC Biopharma Submit IND for Phase 3 Trial of Barycela in Thailand
28 Aug 2025 //
PR NEWSWIRE
GC Biopharma, Thai Red Cross Society to Boost Plasma-Derived
18 Aug 2025 //
PR NEWSWIRE
Gc Biopharma Gets Approval to Market Barycela in Vietnam
17 Jul 2025 //
PR NEWSWIRE
GC Biopharma gets FDA approval for US Plasma Center in Calexico
14 May 2025 //
PR NEWSWIRE
Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO
13 Jan 2025 //
BUSINESSWIRE
AOM Infusion Partners with Alyglo for Immunoglobulin Therapy
26 Nov 2024 //
BUSINESSWIRE
GC Biopharma and Novelty Nobility Join for Geographic Atrophy R&D
28 Oct 2024 //
PR NEWSWIRE
The World`s First "Recombinant Anthrax Vaccine"
05 Nov 2023 //
PR NEWSWIRE
Immetas Therapeutics and GC Biopharma Announce Research Collaboration
12 Oct 2023 //
BUSINESSWIRE
GC Biopharma and Eubiologics enter deal to produce cholera vaccine
28 Aug 2023 //
PHARMACEUTICAL TECHNOLOGY
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics
25 Aug 2023 //
PR NEWSWIRE
U.S. FDA Accepts BLA for GC Biopharma`s GC5107B, 10% Liquid)
31 Jul 2023 //
PR NEWSWIRE
U.S. FDA Accepts Biologics License Application for GC Biopharma`s GC5107B
31 Jul 2023 //
PR NEWSWIRE
GC Biopharma`s "GC FLU" obtains vaccine approval in Egypt
21 Jul 2023 //
PR NEWSWIRE
GC Biopharma Receives WHO Pre-Qualification for BARYCELA
19 Feb 2023 //
PR NEWSWIRE

Market Place
Sourcing Support